Business Context and Reporting Period
This Form 6-K filing by Fresenius Medical Care AG & Co. KGaA, dated March 23, 2009, serves as a notification regarding the publication of the agenda and invitation for the 2009 Annual General Meeting (AGM) of Ordinary Shareholders. The AGM is scheduled for May 7, 2009. The filing also references the availability of the 2008 Annual Report and the Supervisory Board report on the company's website.
Financial Metrics
The filing text does not provide specific financial values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to distribute meeting materials rather than a financial results report. Detailed financial data for the fiscal year 2008 is contained in the referenced Annual Report on Form 20-F and the 2008 Annual Report, which are posted on the company's website but not included in this text.
Material Changes
No material changes to financial performance or operations are reported in this specific filing. The document focuses on corporate governance procedures, specifically the distribution of AGM materials to shareholders and American Depositary Receipt (ADR) holders.
Guidance, Outlook, and Risks
The filing does not contain management guidance, future outlook, or specific risk factors. It notes that the ADR Depositary will distribute supplemental information to ADR holders on or about April 2, 2009. This supplemental information covers security ownership, trading markets, director and management compensation, stock options, and material transactions between the company and its controlling persons.
Key Facts for Investor Verification
- Verify the date and agenda of the 2009 Annual General Meeting scheduled for May 7, 2009.
- Review the 2008 Annual Report and Form 20-F on the company website for actual financial performance data.
- Check for the distribution of voting instruction cards and supplemental information to ADR holders expected around April 2, 2009.
- Confirm the contents of the Supplemental Information regarding executive compensation and related-party transactions.